Novavax Inc
NASDAQ: NVAX
$7.22
-$0.55 (-7.0%)
Closing Price on November 14, 2024
NVAX Articles
Novavax has announced positive top-line data from a Phase 2 clinical trial of its RSV F-protein recombinant nanoparticle vaccine candidate to protect infants via maternal immunization.
Published:
Despite the market falling on Tuesday, Novavax bucked the trend and was up handily, after a Phase 2 breakthrough with its RSV candidate.
Published:
Novavax is on the precipice of vaccinating Ebola, or at least according to its most recent clinical trial.
Published:
In a week that saw big up and down swings, insiders certainly do not look panicked to sell shares, and that is a positive.
Published:
With April coming to a close on Thursday, it is time for yet another rebalancing of some of the biggest indexes on Wall Street.
Published:
Last Updated:
This past week we tracked seven key analyst calls with big upside in stocks that were trading under $10 when the analysts made their calls.
Published:
Tuesday's top analyst upgrades and downgrades include American Express, BIND Therapeutics, Devon Energy, General Motors, Novavax and Toyota.
Published:
The last full week of March was choppy and took away most of the 2015 gains for the Dow and the S&P. Still, investors keep looking for value.
Published:
Friday's top analyst upgrades and downgrades include Cisco Systems, EMC, GameStop, Novavax, Tesla Motors and Yahoo.
Published:
Thursday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include Crocs, Halliburton, Nuance Communications, Staples and Yelp.
Published:
What we are continuing to see is that big sell-offs are still bringing in buyers who are on the hunt for oversold and overlooked stocks.
Published:
These are the top analyst upgrades, downgrades and initiations seen on Tuesday, October 7, 2014.
Published:
A Cowen report zeroes in on the most illiquid stocks that will be traded Wednesday as 15 ETFs rebalance.
Published:
ThinkstockStocks had a crazy end to the week on reports of tension escalation and fighting in Ukraine and Russia. Still, investors are looking to use market weakness to find bargain stocks. Perhaps...
Published:
Jon OggStocks were well up on Wednesday morning. While volatility has returned to the stock market, it seems as though investors are looking to accumulate stocks that have sold off and that were...
Published: